Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C

Hepatology

Volumn 37, Issue 5, 2003, Pages 1189-1198

  Ulsenheimer, Axel ^a   Gerlach, J Tilman ^a,b   Gruener, Norbert H ^a,b   Jung, Maria Christina ^a,b   Schirren, Carl Albrecht ^b   Schraut, Winfried ^a   Zachoval, Reinhart ^b   Pape, Gerd R ^a,b   Diepolder, Helmut M ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ACUTE HEPATITIS; ADULT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL COUNT; CELL SPECIFICITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; DISEASE MARKER; FEMALE; HELPER CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS DETECTION; VIRUS INFECTIVITY;

EID: 0038374730     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50194     Document Type: Article

References (34)

1. Alter MJ. Epidemiology of hepatitis C. HEPATOLOGY 1997;26:62S-65S.
2. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000;20:1-16.
3. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000;132:296-305.
4. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995;346:1006-1007.
5. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996;98:706-714.
6. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chtonicity. HEPATOLOGY 1997;25:449-458.
7. Valitutti S, Muller S, Dessing M, Lanzavecchia A. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med 1996;183:1917-1921.
8. Diepoldet HM, Gtuenet NH, Gerlach JT, Jung MC, Wietenga EA, Pape GR. Different levels of T-cell receptor triggering induce distinct functions in hepatitis B and hepatitis C virus-specific human CD4+ T cell clones. J Vitol 2001;75:7803-7810.
9. Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, Hoffmann R, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999;117:933-941.
10. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364.
11. Diepolder HM, Gerlach JT, Zachoval R, Hoffmann RM, Jung MC, Wierenga EA, Scholz S, et al. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 1997;71:6011-6019.
12. Jung MC, Hartmann B, Gerlach JT, Diepolder H, Gruber R, Schraut W, Gtuner N, et al. Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection. Virology 1999;261:165-172.
13. Zinkernagel RM, Hengartner H. Antiviral immunity. Immunol Today 1997;18:258-260.
14. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
15. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000;290:92-97.
16. Pulendran B, Palucka K, Banchereau J. Sensing pathogens and tuning immune responses. Science 2001;293:253-256.
17. Zinkernagel RM, Hengartner H. Regulation of the immune response by antigen. Science 2001;293:251-253.
18. Lanzavecchia A, Sallusto F. Antigen decoding by T lymphocytes: from synapses to fate determination. Nat Immunol 2001;2:487-492.
19. Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000;192:63-75.
20. Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, Walker B, et al. Sustained dysfunction of antiviral CD8(+) T lymphocytes after infection with hepatitis C virus. J Virol 2001;75:5550-5558.
21. Lucas M, Ulsenheimer A, Wyer J, Cunliffe S, Harcourt G, Diepolder HM, McMichael A, et al. HCV specific CD4+ cell responses studied using MHC class II tetramers. 9th International Meeting on HCV and Related Viruses, 2002. San Diego, CA.
22. Tanchot C, Barber DL, Chiodetti L, Schwartz RH. Adaptive tolerance of CD4+ T cells in vivo: multiple thresholds in response to a constant level of antigen presentation. J Immunol 2001;167:2030-2039.
23. Ogg GS, McMichael AJ. HLA-peptide tetrameric complexes. Curr Opin Immunol 1998;10:393-396.
24. Godkin A, Jeanguet N, Thursz M, Openshaw P, Thomas H. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Eur J Immunol 2001;31:1438-1446.
25. Kamal SM, Rasenack JW, Bianchi L, Al Tawil A, El Sayed Khalifa K, Peter T, Mansour H, et al. Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response. Gastroenterology 2001;121:646-656.
26. Hori S, Carvalho TL, Demengeot J. CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 2002;32:1282-1291.
27. Germain RN. The art of the probable: system control in the adaptive immune system. Science 2001;293:240-245.
28. Sprent J, Surh CD. Generation and maintenance of memory T cells. Curr Opin Immunol 2001;13:248-254.
29. Sprent J, Tough DF. T cell death and memory. Science 2001;293:245-248.
30. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, Miller JL, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000;6:578-582.
31. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993;362:758-761.
32. Gallimore A, Glithero A, Godkin A, Tissot AC, Pluckthun A, Elliott T, Hengartner H, et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med 1998;187:1383-1393.
33. Oxenius A, Zinkemagel RM, Hengartner H. Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. Immunity 1998;9:449-457.
34. Rocha B, Grandien A, Freitas AA. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J Exp Med 1995;181:993-1003.